Skip to content

Total β- Human Chorionic Gonadotropin (CLIA)

by Medcaptain Medical Technology Co., Ltd. United States EUDAMED

Ref MCL05801E EMDN W0102050205

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD Number69268026MD761F0000000013C Basic UDI-DIDate25 Jun 2026RegisteredStatusActive
European UnionCE/IVDR Number69268026MD761F0000000013C Basic UDI-DIDate25 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD, CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Device Name
Total β- Human Chorionic Gonadotropin (CLIA)
Total β-Human Chorionic Gonadotropin (CLIA)
Model / Reference
MCL05801E
Primary DI / UDI-DI
06926802605356
Basic UDI-DI
69268026MD761F0000000013C, B-06926802605356
EMDN Code
W0102050205 Total human chorionic gonadotropin
Device Class
Class C
Class IVD General
Market of Registration
Netherlands

Manufacturer details

EUDAMED SRN
CN-MF-000005925
Authorised representative
R Sight B.V. NL-AR-000010445

Other devices from Medcaptain Medical Technology Co., Ltd.

See all devices from Medcaptain Medical Technology Co., Ltd. →

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (2)

  • EUDAMED 06926802605356|69268026MD761F0000000013C 61 fields · synced 25 Oct 2026
  • EUDAMED 06926802605356|B-06926802605356 61 fields · synced 25 Oct 2026